What Is Asthma? Airways, Triggers, and Treatment

The Biology of Asthmatic Airways

Asthma is characterized by three interrelated processes in the airways: chronic inflammation, bronchospasm (tightening of the smooth muscles surrounding the airways), and mucus hypersecretion. Together, these processes narrow the lumen of the bronchi and bronchioles, making it difficult for air to move in and out of the lungs. The inflammatory component means that the airways are perpetually in a sensitized state, making them hyperresponsive to a wide range of stimuli.

In a healthy airway, the immune response to harmless particles is muted. In asthma, particularly allergic asthma, the immune system mounts an exaggerated response mediated by IgE antibodies and Th2 helper T-cells, which trigger the release of histamine, leukotrienes, and interleukins. These inflammatory mediators cause the characteristic swelling, mucus production, and muscle contraction that produce asthma symptoms: wheezing, shortness of breath, chest tightness, and cough—especially at night or in the early morning.

Types of Asthma

Allergic asthma is the most common type, accounting for roughly 60% of cases. It is triggered by allergens such as dust mites, pet dander, pollen, and mold. Patients typically have other atopic conditions such as hay fever or eczema, and their blood and sputum show elevated eosinophil counts.

Exercise-induced bronchoconstriction (EIB) occurs during or after vigorous physical activity, when breathing rapidly through the mouth bypasses the nose's warming and humidifying function, delivering cold, dry air directly to sensitive airways. Up to 90% of people with asthma experience EIB, but it also affects about 10% of the general population without an asthma diagnosis. Occupational asthma is caused by workplace exposures to chemicals, dust, or fumes. Non-allergic asthma (intrinsic asthma) is triggered by irritants like cigarette smoke, air pollution, respiratory infections, and strong emotions rather than allergens, and tends to have a later onset and be more severe.

Diagnosis and Spirometry

Asthma diagnosis relies on a combination of clinical history, symptom pattern, and objective lung function testing. The characteristic feature is reversible airflow obstruction—airway narrowing that improves spontaneously or with bronchodilator treatment. Spirometry is the gold-standard pulmonary function test. It measures the forced expiratory volume in one second (FEV1) and the forced vital capacity (FVC). An FEV1/FVC ratio below 0.7 indicates obstruction, and a 12% or greater improvement in FEV1 following a bronchodilator confirms reversibility consistent with asthma.

Additional diagnostic tools include peak flow monitoring (a portable device measuring maximum expiratory flow rate), bronchial challenge tests using methacholine or exercise in patients with normal baseline spirometry, and fractional exhaled nitric oxide (FeNO), which is a marker of eosinophilic airway inflammation. Allergy skin-prick tests or specific IgE blood tests identify relevant allergens in patients with suspected allergic asthma.

Reliever vs. Preventer Inhalers

Reliever inhalers (also called rescue inhalers) contain short-acting beta-2 agonists (SABAs) such as salbutamol (albuterol). They act within minutes to relax airway smooth muscle, providing rapid symptom relief during an acute episode. They are not anti-inflammatory and do not address the underlying disease—relying on them more than twice a week signals that asthma is not adequately controlled.

Preventer inhalers contain inhaled corticosteroids (ICS) such as beclomethasone, budesonide, or fluticasone. Taken daily, they reduce airway inflammation over time, preventing symptoms from occurring. ICS are the cornerstone of long-term asthma management. For patients not controlled on ICS alone, long-acting beta-2 agonists (LABAs) such as salmeterol or formoterol are added to the preventer. Combination ICS/LABA inhalers (e.g., Symbicort, Advair) simplify regimens and improve adherence. Newer biological therapies, such as dupilumab and mepolizumab, target specific inflammatory pathways for patients with severe, refractory eosinophilic asthma.

Asthma Action Plans

A written asthma action plan is a personalized document that guides patients on how to adjust medications in response to changing symptoms or peak flow readings. It uses a traffic-light system: green (well-controlled, continue regular treatment), yellow (worsening, increase reliever use and consider oral corticosteroids), and red (severe episode requiring emergency care). Studies consistently show that patients with written action plans have fewer hospitalizations and better quality of life.

Environmental trigger avoidance is an equally important management pillar. Encasing mattresses and pillows in allergen-proof covers, using HEPA air filters, eliminating smoking indoors, and managing indoor humidity to reduce mold growth can significantly reduce allergen load. Patients with occupational asthma may require a change of work environment. Regular review by a healthcare provider ensures that treatment is stepped up when needed and stepped down when asthma is stable, minimizing side effects while maintaining control.

Living with Asthma

With appropriate management, the vast majority of people with asthma can lead fully active lives, including participating in competitive sport. Several elite athletes have asthma and manage it effectively with proper medication and preparation. The key is consistent use of preventer treatment, awareness of personal triggers, and having a clear plan for managing deteriorations. Asthma is not curable, but it is highly controllable, and the goal of modern asthma care is zero symptom days and zero limitation on activity.